Use of Opioid-Sparing Protocols and Perceived Postpartum Pain in Patients with Opioid Use Disorder and Chronic Prenatal Opioid Exposure.
Opioid use disorder
Opioid-sparing protocols
Pain management
Pregnancy
Journal
Maternal and child health journal
ISSN: 1573-6628
Titre abrégé: Matern Child Health J
Pays: United States
ID NLM: 9715672
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
accepted:
19
05
2023
medline:
19
6
2023
pubmed:
2
6
2023
entrez:
2
6
2023
Statut:
ppublish
Résumé
Opioid-sparing protocols reduce postpartum opioid prescribing in opioid-naïve patients; however, patients with opioid use disorder (OUD) and complex pain needs who may benefit from these protocols are typically excluded from them. We assessed postpartum pain experiences of patients with OUD and chronic prenatal opioid exposure after implementation of an opioid-sparing protocol. A phone survey assessed postpartum pain experiences for people with chronic prenatal opioid exposure who delivered between January 2020 and August 2021 at an academic hospital. Analyses included descriptive statistics, qualitative content analysis, and a joint display comparing themes. Of 25 patients, 18 (72%) participated; most were non-Hispanic White (100%, 18/18), publicly insured (78%, 14/18), multiparous (78%, 14/18), with OUD (100%, 18/18). No patients with a vaginal birth received an opioid prescription; half (4/8) with a cesarean birth received one at discharge. Over one-third (7/18, 39%) reported poor pain control (≥ 5/10) in the hospital and one week post-discharge; scores were higher for cesarean versus vaginal birth. Qualitative sub-analyses of open-ended responses revealed patient perceptions of postpartum pain and treatment. The most effective strategies, stratified by birth type and pain level, ranged from non-opioid medications for vaginal births and minor pain to prescription opioids for cesarean births and moderate-to-intense pain. Postpartum opioid prescribing for patients with chronic prenatal opioid use was low for vaginal and cesarean birth following implementation of an opioid-sparing protocol. Patients with OUD reported good pain management with opioid-sparing pain regimens; however, many reported poorly controlled pain immediately postpartum. Future work should assess approaches to postpartum pain management that minimize the risks of opioid medication-particularly in at-risk groups. What is already known on this subject? Opioid-sparing protocols can reduce postpartum opioid prescribing in opioid-naïve patients; however, there are currently no clear guidelines for opioid prescribing for people with opioid use disorder (OUD) in the postpartum period.What this study adds?Postpartum opioid prescribing for patients with chronic prenatal opioid use was less than the national average and one-third of patients reported poor pain control. Opioid-sparing protocols postpartum should be expanded to patients with OUD to improve pain control and minimize risks associated with opioid medication.
Autres résumés
Type: plain-language-summary
(eng)
What is already known on this subject? Opioid-sparing protocols can reduce postpartum opioid prescribing in opioid-naïve patients; however, there are currently no clear guidelines for opioid prescribing for people with opioid use disorder (OUD) in the postpartum period.What this study adds?Postpartum opioid prescribing for patients with chronic prenatal opioid use was less than the national average and one-third of patients reported poor pain control. Opioid-sparing protocols postpartum should be expanded to patients with OUD to improve pain control and minimize risks associated with opioid medication.
Identifiants
pubmed: 37266855
doi: 10.1007/s10995-023-03710-8
pii: 10.1007/s10995-023-03710-8
pmc: PMC10235822
doi:
Substances chimiques
Analgesics, Opioid
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1416-1425Subventions
Organisme : NCATS NIH HHS
ID : UL1TR002240
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1TR002240
Pays : United States
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Alford, D. P., Compton, P., & Samet, J. H. (2006). Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. Annals of Internal Medicine, 144(2), 127–134. https://doi.org/10.7326/0003-4819-144-2-200601170-00010
doi: 10.7326/0003-4819-144-2-200601170-00010
pubmed: 16418412
pmcid: 1892816
American College of Obstetricians and Gynecologists. (2017). Committee opinion No. 711: Opioid use and opioid use disorder in pregnancy. Obstetrics & Gynecology, 130(2), e81–e94. https://doi.org/10.1097/AOG.0000000000002235
doi: 10.1097/AOG.0000000000002235
Anderson, M., Hallway, A., Brummett, C., Waljee, J., Englesbe, M., & Howard, R. (2021). Patient-reported outcomes after opioid-sparing surgery compared with standard of care. JAMA Surgery, 156(3), 286–287. https://doi.org/10.1001/jamasurg.2020.5646
doi: 10.1001/jamasurg.2020.5646
pubmed: 33502440
pmcid: 7841573
Angst, M. S., & Clark, J. D. (2006). Opioid-induced hyperalgesia: A qualitative systematic review. Anesthesiology, 104(3), 570–587. https://doi.org/10.1097/00000542-200603000-00025
doi: 10.1097/00000542-200603000-00025
pubmed: 16508405
Bateman, B. T., Franklin, J. M., Bykov, K., Avorn, J., Shrank, W. H., Brennan, T. A., Landon, J. E., Rathmell, J. P., Huybrechts, K. F., Fischer, M. A., & Choudhry, N. K. (2016). Persistent opioid use following cesarean delivery: Patterns and predictors among opioid-naive women. American Journal of Obstetrics and Gynecology, 215(3), 353 e1-353 e18. https://doi.org/10.1016/j.ajog.2016.03.016
doi: 10.1016/j.ajog.2016.03.016
pubmed: 26996986
Centers for Disease Control and Prevention. (2011). Vital signs: Overdoses of prescription opioid pain relievers–-United States, 1999–2008. Morbidity and Mortality Weekly Report, 60(43), 1487–1492.
Falletta, L., Hamilton, K., Fischbein, R., Aultman, J., Kinney, B., & Kenne, D. (2018). Perceptions of child protective services among pregnant or recently pregnant, opioid-using women in substance abuse treatment. Child Abuse and Neglect, 79, 125–135. https://doi.org/10.1016/j.chiabu.2018.01.026
doi: 10.1016/j.chiabu.2018.01.026
pubmed: 29433069
Goodman, D. J., Saunders, E. C., & Wolff, K. B. (2020). In their own words: A qualitative study of factors promoting resilience and recovery among postpartum women with opioid use disorders. BMC Pregnancy and Childbirth, 20(1), 178. https://doi.org/10.1186/s12884-020-02872-5
doi: 10.1186/s12884-020-02872-5
pubmed: 32188411
pmcid: 7081623
Hallway, A., Vu, J., Lee, J., Palazzolo, W., Waljee, J., Brummett, C., Englesbe, M., & Howard, R. (2019). Patient satisfaction and pain control using an opioid-sparing postoperative pathway. Journal of the American College of Surgeons, 229(3), 316–322. https://doi.org/10.1016/j.jamcollsurg.2019.04.020
doi: 10.1016/j.jamcollsurg.2019.04.020
pubmed: 31154092
pmcid: 7596906
Hedderson, M., Lee, D., Hunt, E., Lee, K., Xu, F., Mustille, A., Galin, J., Campbell, C., Quesenberry, C., Reyes, V., Huang, M., Nicol, B., Paulson, S., & Liu, V. (2019). Enhanced recovery after surgery to change process measures and reduce opioid use after cesarean delivery: A quality improvement initiative. Obstetrics & Gynecology, 134(3), 511–519. https://doi.org/10.1097/AOG.0000000000003406
doi: 10.1097/AOG.0000000000003406
Hirai, A. H., Ko, J. Y., & Patrick, S. W. (2021). US hospital data about neonatal abstinence syndrome and maternal opioid-related diagnoses-reply. JAMA, 325(20), 2120. https://doi.org/10.1001/jama.2021.4519
doi: 10.1001/jama.2021.4519
pubmed: 34032835
Howard, R., Fry, B., Gunaseelan, V., Lee, J., Waljee, J., Brummett, C., Campbell, D., Jr., Seese, E., Englesbe, M., & Vu, J. (2019). Association of opioid prescribing with opioid consumption after surgery in Michigan. JAMA Surgery, 154(1), e184234. https://doi.org/10.1001/jamasurg.2018.4234
doi: 10.1001/jamasurg.2018.4234
pubmed: 30422239
Lakhi, N., Tricorico, G., Kanninen, T., Suddle, R., Ponterio, J., & Moretti, M. (2019). Post-cesarean delivery outpatient opioid consumption and perception of pain control following implementation of a restrictive opioid prescription protocol. American Journal of Obstetrics & Gynecology MFM, 1(4), 100049. https://doi.org/10.1016/j.ajogmf.2019.100049
doi: 10.1016/j.ajogmf.2019.100049
Maeda, A., Bateman, B. T., Clancy, C. R., Creanga, A. A., & Leffert, L. R. (2014). Opioid abuse and dependence during pregnancy: Temporal trends and obstetrical outcomes. Anesthesiology, 121(6), 1158–1165. https://doi.org/10.1097/ALN.0000000000000472
doi: 10.1097/ALN.0000000000000472
pubmed: 25405293
Mitra, A., Brandt, J., Rosen, T., Ananth, C., & Schuster, M. (2020). Opioid use disorder: A poorly understood cause of maternal mortality in the United States [26E]. Obstetrics & Gynecology, 135(Suppl 1), 56S. https://doi.org/10.1097/01.AOG.0000663364.06637.15
doi: 10.1097/01.AOG.0000663364.06637.15
O’Rourke-Suchoff, D., Sobel, L., Holland, E., Perkins, R., Saia, K., & Bell, S. (2020). The labor and birth experience of women with opioid use disorder: A qualitative study. Women Birth, 33(6), 592–597. https://doi.org/10.1016/j.wombi.2020.01.006
doi: 10.1016/j.wombi.2020.01.006
pubmed: 31987751
Peahl, A. F., Dalton, V. K., Montgomery, J. R., Lai, Y. L., Hu, H. M., & Waljee, J. F. (2019). Rates of new persistent opioid use after vaginal or cesarean birth among US women. JAMA Network Open, 2(7), e197863. https://doi.org/10.1001/jamanetworkopen.2019.7863
doi: 10.1001/jamanetworkopen.2019.7863
pubmed: 31348508
pmcid: 6661716
Peahl, A. F., Novara, A., Heisler, M., Dalton, V. K., Moniz, M. H., & Smith, R. D. (2020). Patient preferences for prenatal and postpartum care delivery: A survey of postpartum women. Obstetrics & Gynecology, 135(5), 1038–1046. https://doi.org/10.1097/AOG.0000000000003731
doi: 10.1097/AOG.0000000000003731
Rowe, C., Santos, G. M., Behar, E., & Coffin, P. O. (2016). Correlates of overdose risk perception among illicit opioid users. Drug and Alcohol Dependence, 159, 234–239. https://doi.org/10.1016/j.drugalcdep.2015.12.018
doi: 10.1016/j.drugalcdep.2015.12.018
pubmed: 26754425
Roxanne, B., Laura, V. D. B., Yannic, V. G., Natacha, V. C., Luka, V. L., & Kuipers, Y. J. (2022). Validation of the postpartum bonding questionnaire: A cross-sectional study among Flemish mothers. Midwifery, 107, 103280. https://doi.org/10.1016/j.midw.2022.103280
doi: 10.1016/j.midw.2022.103280
pubmed: 35182820
Schiff, D. M., Nielsen, T., Terplan, M., Hood, M., Bernson, D., Diop, H., Bharel, M., Wilens, T. E., LaRochelle, M., Walley, A. Y., & Land, T. (2018). Fatal and nonfatal overdose among pregnant and postpartum women in Massachusetts. Obstetrics & Gynecology, 132(2), 466–474. https://doi.org/10.1097/AOG.0000000000002734
doi: 10.1097/AOG.0000000000002734
Shinnick, J. K., Ruhotina, M., Has, P., Kelly, B. J., Brousseau, E. C., O’Brien, J., & Peahl, A. F. (2020). Enhanced recovery after surgery for cesarean delivery decreases length of hospital stay and opioid consumption: A quality improvement initiative. American Journal of Perinatology. https://doi.org/10.1055/s-0040-1709456
doi: 10.1055/s-0040-1709456
pubmed: 32485757
Soens, M. A., He, J., & Bateman, B. T. (2019). Anesthesia considerations and post-operative pain management in pregnant women with chronic opioid use. Seminars in Perinatology, 43(3), 149–161. https://doi.org/10.1053/j.semperi.2019.01.004
doi: 10.1053/j.semperi.2019.01.004
pubmed: 30791974
U.S. Department of Health and Human Services. (2019). HHS Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics. Retrieved November 15, 2022 from https://www.hhs.gov/opioids/sites/default/files/2019-10/Dosage_Reduction_Discontinuation.pdf